Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS safety_alert · 2026-03-09Clinical Trial Update: A Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA® (Leflunomide) in Saudi Arabia
A regulatory study assessing the effectiveness of additional risk minimization measures for ARAVA (Leflunomide) in Saudi Arabia. It focuses …
-
EMA safety_alert · 2019-07-12PRAC recommends new measures to avoid dosing errors with methotrexate
The EMA's Pharmacovigilance Risk Assessment Committee (PRAC) recommends new measures to prevent dosing errors with methotrexate, including e…
-
EMA safety_alert · 2019-05-17Restrictions in use of Xeljanz while EMA reviews risk of blood clots in lungs
The EMA announced restrictions on the use of Xeljanz (tofacitinib) while it reviews the risk of blood clots in the lungs, indicating potenti…
-
EMA safety_alert · 2019-03-20Increased risk of blood clots in lungs and death with higher dose of Xeljanz (tofacitinib) for rheumatoid arthritis
EMA warns that higher doses of tofacitinib (Xeljanz) for rheumatoid arthritis are associated with an increased risk of blood clots in the lu…
-
CLINICAL_TRIALS safety_alert · 2016-01-14Clinical Trial Update: Hair Fall in Patients on Low Dose Methotrexate
Clinical trial update notes hair loss (alopecia) in patients taking low-dose methotrexate. This adverse reaction is highlighted for people w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS safety_alert · 2015-12-14Clinical Trial Update: Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis
Clinical trial update examining the risk of coccidioidomycosis in patients with inflammatory arthritis treated with anti-TNF and other biolo…
-
CLINICAL_TRIALS safety_alert · 2012-06-29Clinical Trial Update: Rituximab-induced Pulmonary Function Changes
A clinical trial update reports changes in pulmonary function associated with rituximab in patients with rheumatoid arthritis and inflammato…